The proportions of 22 tumor immune cell types are shown in Fig. 6B. Patients with LUAD with high NLRC3 expression had significantly higher proportions of memory B cells, CD8+ T cells, memory CD4+ T cells, follicular T helper (TH) cells, regulatory T cells, activated NK cells, and M1 macrophages (P < 0.05). This evidence concerns the gene NLRC3 and neoplasm.